ARTICLE
29 September 2014

Bill To Fix Sunscreen Ingredient Approval Process Clears The Senate

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
The Senate has passed the Sunscreen Innovation Act through a unanimous consent agreement.
United States Food, Drugs, Healthcare, Life Sciences

The Senate has passed the Sunscreen Innovation Act through a unanimous consent agreement. The bill, which passed the House of Representatives in late July 2014, aims to streamline how new ingredients for over-the-counter sunscreen products are approved. The sunscreen bill now returns to the House of Representatives for further action. Several over-the-counter sunscreen ingredients have languished in the current FDA approval process for 12 years, with the last ingredient being approved in the 1990s. Concerns that consumers in the U.S. were not able to take advantage of new sunscreen technologies prompted Congress to investigate and address the backlog.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More